1 - 25 of
36
results
for author:"Harlow E."
in Literature Citations
| Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiae. Hu Y., Rolfs A., Bhullar B., Murthy T.V.S., Zhu C., Berger M.F., Camargo A.A., Kelley F., McCarron S., Jepson D. et al. Genome Res. 17:536-543(2007) · UniProtKB (1,727) |
| A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Johnson B.R., Nitta R.T., Frock R.L., Mounkes L., Barbie D.A., Stewart C.L., Harlow E., Kennedy B.K. Proc. Natl. Acad. Sci. U.S.A. 101:9677-9682(2004) · Mapped (17) |
| Dp1 is required for extra-embryonic development. Kohn M.J., Bronson R.T., Harlow E., Dyson N.J., Yamasaki L. Development 130:1295-1305(2003) · Mapped (18) |
| The retinoblastoma tumour suppressor in development and cancer. Classon M., Harlow E. Nat. Rev. Cancer 2:910-917(2002) · Mapped (18) |
| Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Fingar D.C., Salama S., Tsou C., Harlow E., Blenis J. Genes Dev. 16:1472-1487(2002) · Mapped (20) |
| Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome. Lee S.B., Kim S.H., Bell D.W., Wahrer D.C.R., Schiripo T.A., Jorczak M.M., Sgroi D.C., Garber J.E., Li F.P., Nichols K.E. et al. |
| Histone deacetylase-dependent transcriptional repression by pRB in yeast occurs independently of interaction through the LXCXE binding cleft. Kennedy B.K., Liu O.W., Dick F.A., Dyson N., Harlow E., Vidal M. Proc. Natl. Acad. Sci. U.S.A. 98:8720-8725(2001) · Mapped (2) |
| A large-scale overexpression screen in Saccharomyces cerevisiae identifies previously uncharacterized cell cycle genes. Stevenson L.F., Kennedy B.K., Harlow E. Proc. Natl. Acad. Sci. U.S.A. 98:3946-3951(2001) · Mapped (69) |
| NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Zhao J., Kennedy B.K., Lawrence B.D., Barbie D.A., Matera A.G., Fletcher J.A., Harlow E. Genes Dev. 14:2283-2297(2000) · UniProtKB (1) |
| Disruption of retinoblastoma protein family function by human papillomavirus type 16 E7 oncoprotein inhibits lens development in part through E2F-1. McCaffrey J., Yamasaki L., Dyson N.J., Harlow E., Griep A.E. Mol. Cell. Biol. 19:6458-6468(1999) · Mapped (3) |
| Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Pan H., Yin C., Dyson N.J., Harlow E., Yamasaki L., Van Dyke T. Mol. Cell 2:283-292(1998) · Mapped (3) |
| pRB plays an essential role in cell cycle arrest induced by DNA damage. Harrington E.A., Bruce J.L., Harlow E., Dyson N. Proc. Natl. Acad. Sci. U.S.A. 95:11945-11950(1998) · Mapped (12) |
| Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Yamasaki L., Bronson R., Williams B.O., Dyson N.J., Harlow E., Jacks T. Nat. Genet. 18:360-364(1998) · Mapped (9) |
| Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Zhao J., Dynlacht B., Imai T., Hori T., Harlow E. Genes Dev. 12:456-461(1998) · UniProtKB (1) |
| Specific regulation of E2F family members by cyclin-dependent kinases. Dynlacht B.D., Moberg K., Lees J.A., Harlow E., Zhu L. Mol. Cell. Biol. 17:3867-3875(1997) · UniProtKB (1) |
| New functional activities for the p21 family of CDK inhibitors. LaBaer J., Garrett M.D., Stevenson L.F., Slingerland J.M., Sandhu C., Chou H.S., Fattaey A., Harlow E. Genes Dev. 11:847-862(1997) · Mapped (6) |
| Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Vidal M., Brachmann R.K., Fattaey A., Harlow E., Boeke J.D. Proc. Natl. Acad. Sci. U.S.A. 93:10315-10320(1996) · Mapped (1) |
| Shared role of the pRB-related p130 and p107 proteins in limb development. Cobrinik D., Lee M.H., Hannon G., Mulligan G., Bronson R.T., Dyson N., Harlow E., Beach D., Weinberg R.A., Jacks T. Genes Dev. 10:1633-1644(1996) · Mapped (6) |
| Targeted disruption of p107: functional overlap between p107 and Rb. Lee M.H., Williams B.O., Mulligan G., Mukai S., Bronson R.T., Dyson N., Harlow E., Jacks T. Genes Dev. 10:1621-1632(1996) · Mapped (12) |
| Tumor induction and tissue atrophy in mice lacking E2F-1. Yamasaki L., Jacks T., Bronson R., Goillot E., Harlow E., Dyson N.J. Cell 85:537-548(1996) · Mapped (3) |
| Characterization of the retinoblastoma binding proteins RBP1 and RBP2. Fattaey A.R., Helin K., Dembski M.S., Dyson N., Harlow E., Vuocolo G.A., Hanobik M.G., Haskell K.M., Oliff A., Defeo-Jones D. et al. Oncogene 8:3149-3156(1993) · UniProtKB (3) |
| Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Helin K., Harlow E., Fattaey A. Mol. Cell. Biol. 13:6501-6508(1993) · UniProtKB (1) |
| Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Helin K., Wu C.-L., Fattaey A.R., Lees J.A., Dynlacht B.D., Ngwu C., Harlow E. |
| Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Zhu L., van den Heuvel S., Helin K., Fattaey A., Ewen M., Livingston D., Dyson N., Harlow E. Genes Dev. 7:1111-1125(1993) · UniProtKB (1) |
| Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Tsai L.H., Takahashi T., Caviness V.S. Jr., Harlow E. Development 119:1029-1040(1993) · Mapped (2) |
